STARTUP PROFILE

Newronika

COUNTRY
Italy
FOUNDED
2016
CATEGORY
Neuromodulation
Developing AlphaDBS, a closed-loop deep brain stimulation implant that adapts therapy in real-time based on brain signals to treat Parkinson’s disease.
Visit website →
Neurofounders Insights
$   Funding   -
Series B
MODALITY
DBS
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Parkinson's
TARGET USER
Patients
REGULATORY STAGE
CE-Marked
Newronika is among the leading closed-loop DBS startups, using adaptive stimulation based on recorded neural signals for Parkinson’s disease. Its CE-marked status and focused indication make it one of the more concrete challengers to incumbent DBS manufacturers.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Newronika